Repligen (RGEN) Tops Q1 EPS by 4c, provides guidance

Repligen (NASDAQ: RGEN) reported Q1 EPS of $0.39, $0.04 better than the analyst estimate of $0.35. Revenue for the quarter came in at $169 million versus the consensus estimate of $163.4 million.

GUIDANCE:

Repligen sees FY2025 EPS of $1.63-$1.72, versus the consensus of $1.71.

For earnings history and earnings-related data on Repligen (RGEN) click here.

You May Also Be Interested In

• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• Gordon Haskett cuts TJX Companies rating to Accumulate
• Autohome (ATHM) Tops Q2 EPS by 42c